HealthEquity (HQY) Reports In-Line Q3 EPS, FY EPS Guidances Misses Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Raymond James Downgrades HealthEquity, Inc (HQY) to Outperform
December 7, 2021 7:14 AM ESTRaymond James analyst C. Gregory Peters downgraded HealthEquity, Inc (NASDAQ: HQY) from Strong Buy to Outperform with a price target of $70.00 (from $90.00) following results.
The analyst commented, "The stock was down over 20% after hours last night as management lowered guidance (see page 2 for changes in guidance) for FY22 due in part to disappointing Service and Interchange revenue results. Service revenue declined 1.7% y/y to $103M in... More
